OPKO Health, Inc. (OPK) stock
OPKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 9/305% above fair value
$1.57−0.04 (-2.48%)
Close on Nov 20, 2026Market cap $1.17BP/E –Yield –
OPKO Health free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
OPKO Health's free cash flow for the twelve months ending Jun 30, 2026 was -$134.02M. For fiscal 2025 it was -$190.82M. The highest annual figure on record is $153.18M in fiscal 2015.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$190.82M | – |
| FY2024 | Dec 31, 2024 | -$208.50M | – |
| FY2023 | Dec 31, 2023 | -$44.47M | – |
| FY2022 | Dec 31, 2022 | -$119.77M | -2037.7% |
| FY2021 | Dec 31, 2021 | $6.18M | +6.7% |
| FY2020 | Dec 31, 2020 | $5.79M | – |
| FY2019 | Dec 31, 2019 | -$185.26M | – |
| FY2018 | Dec 31, 2018 | -$137.00M | – |
| FY2017 | Dec 31, 2017 | -$138.60M | -1126.8% |
| FY2016 | Dec 31, 2016 | $13.50M | -91.2% |
| FY2015 | Dec 31, 2015 | $153.18M | – |
| FY2014 | Dec 31, 2014 | -$95.11M | – |
| FY2013 | Dec 31, 2013 | -$59.62M | – |
| FY2012 | Dec 31, 2012 | -$26.89M | – |
| FY2011 | Dec 31, 2011 | -$20.45M | – |
| FY2010 | Dec 31, 2010 | -$19.49M | – |
| FY2009 | Dec 31, 2009 | -$23.58M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$46.50M | – |
| Q1 FY2026 | Mar 31, 2026 | -$21.14M | – |
| Q4 FY2025 | Dec 31, 2025 | -$28.59M | – |
| Q3 FY2025 | Sep 30, 2025 | -$37.78M | – |
| Q2 FY2025 | Jun 30, 2025 | -$86.70M | – |
| Q1 FY2025 | Mar 31, 2025 | -$37.75M | – |
| Q4 FY2024 | Dec 31, 2024 | -$49.82M | – |
| Q3 FY2024 | Sep 30, 2024 | -$85.02M | -394.1% |
| Q2 FY2024 | Jun 30, 2024 | -$33.65M | – |
| Q1 FY2024 | Mar 31, 2024 | -$40.01M | – |
| Q4 FY2023 | Dec 31, 2023 | -$41.32M | – |
| Q3 FY2023 | Sep 30, 2023 | $28.91M | – |
| Q2 FY2023 | Jun 30, 2023 | -$6.38M | – |
| Q1 FY2023 | Mar 31, 2023 | -$25.68M | – |
| Q4 FY2022 | Dec 31, 2022 | -$37.96M | – |
| Q3 FY2022 | Sep 30, 2022 | -$39.85M | -252.3% |
| Q2 FY2022 | Jun 30, 2022 | -$16.86M | – |
| Q1 FY2022 | Mar 31, 2022 | -$25.11M | -249.5% |
| Q4 FY2021 | Dec 31, 2021 | -$12.37M | -145.1% |
| Q3 FY2021 | Sep 30, 2021 | $26.16M | -50.9% |
| Q2 FY2021 | Jun 30, 2021 | -$24.40M | – |
| Q1 FY2021 | Mar 31, 2021 | $16.79M | – |
| Q4 FY2020 | Dec 31, 2020 | $27.46M | – |
| Q3 FY2020 | Sep 30, 2020 | $53.28M | – |
| Q2 FY2020 | Jun 30, 2020 | -$25.95M | – |
| Q1 FY2020 | Mar 31, 2020 | -$49.00M | – |
| Q4 FY2019 | Dec 31, 2019 | -$49.91M | – |
| Q3 FY2019 | Sep 30, 2019 | -$26.30M | – |
| Q2 FY2019 | Jun 30, 2019 | -$57.13M | – |
| Q1 FY2019 | Mar 31, 2019 | -$51.92M | – |
| Q4 FY2018 | Dec 31, 2018 | -$37.69M | – |
| Q3 FY2018 | Sep 30, 2018 | -$33.91M | – |
| Q2 FY2018 | Jun 30, 2018 | -$23.90M | – |
| Q1 FY2018 | Mar 31, 2018 | -$41.49M | – |
| Q4 FY2017 | Dec 31, 2017 | -$12.35M | -142.9% |
| Q3 FY2017 | Sep 30, 2017 | -$52.86M | – |
| Q2 FY2017 | Jun 30, 2017 | -$29.93M | – |
| Q1 FY2017 | Mar 31, 2017 | -$43.46M | – |
| Q4 FY2016 | Dec 31, 2016 | $28.77M | – |
| Q3 FY2016 | Sep 30, 2016 | -$36.05M | – |
See a number that looks wrong?